Wells Fargo Rates Bath & Body Works (BBWI) buy, $26 Price Target

Wells Fargo maintains a buy rating on Bath & Body Works, with a price target of $26, a 19.16% upside from the current price.

By EarningsIQ Research Desk · Published Jun 23, 2026, 10:01 AM EDT · Updated Jun 26, 2026, 9:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Wells Fargo rated Bath & Body Works, Inc. ($BBWI) "buy" with a $26 price target on June 23, 2026.

Since the rating, $BBWI is up 11.6% after 1 week, down 6.7% after 1 month and down 1.8% to date (from the $20.51 close on Jun 23, 2026).

BBWI Bath & Body Works, Inc.

$20.14 +0.05% year to date

Daily close · Oct 16, 2026

Key Points

Wells Fargo reiterated its buy rating on Bath & Body Works, Inc. (NYSE:BBWI) with a price target of $26 on June 23, 2026.
Wells Fargo's $26 price target implies 19.16% upside from Bath & Body Works, Inc.'s ($BBWI) current $21.82 share price.
BBWI shares traded at $19.63 on Tuesday, with a market cap of $3.96 billion and a P/E ratio of 5.58.
Insider buying activity includes several purchases on June 11, 2026, by key executives like Interim CFO Tom Javitch.

Get $BBWI trade alerts by text

We text you when insiders, Congress or big funds trade $BBWI. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Bath & Body Works, Inc. alert may contain errors. Disclosures

Wells Fargo reiterated its buy rating on Bath & Body Works, Inc. (NYSE:BBWI) on June 23, 2026. Analyst Ike Boruchow maintained the price target at $26, indicating continued confidence in the company's prospects. Shares of BBWI traded at $19.63 on Tuesday.

Analyst rating track record

Wells Fargo vs. the S&P 500

YTD return -13.21% hypothetical

All-time return +9.28% S&P 500 +34.84%

vs. S&P 500 -25.56% behind the index

Hypothetical returns from Wells Fargo's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in Bath & Body Works

FMR LLC increased its holdings by 3,944,735 shares, bringing its total to 20,888,799 shares valued at approximately $389.99 million, marking a 23.3% increase. BlackRock, Inc. trimmed its position by 1,826,464 shares, holding 19,322,372 shares worth $360.75 million, a decrease of 8.6%. Vanguard Portfolio Management LLC opened a new position with 15,021,767 shares valued at $280.46 million. AQR Capital Management LLC reduced its stake by 405,215 shares, leaving it with 11,040,713 shares valued at $206.13 million, a 3.5% decrease. Meanwhile, D. E. Shaw & Co., Inc. boosted its position significantly by 3,735,358 shares to 9,504,593 shares, valued at $177.45 million, a 64.7% increase.

Bath & Body Works, Inc. Stock Up 25.4%

Shares of Bath & Body Works traded near $19.63 on Tuesday. The company has a market cap of $3.96 billion and a P/E ratio of 5.58. Its stock has a 52-week low of $14.28 and a high of $33.96. The 50-day moving average is $18.81, and the 200-day moving average is $21.55. Bath & Body Works has a beta of 1.387, indicating its stock is more volatile than the market. The current ratio stands at 1.379, with a quick ratio of 0.667.

12-month forecast

$BBWI price target

Bath & Body Works, Inc. daily closes and this analyst's $26 target. Not advice.

Recent Earnings

Bath & Body Works reported revenue of $7.25 billion, with a slight revenue decline of 3.2%. It posted an EPS of $3.52, reflecting a net margin of 10.04%. The next earnings announcement is scheduled for August 27, 2026.

Dividend

The company offers an annual dividend rate of $0.80, yielding 3.89% based on current prices. The dividend payout ratio is a conservative 22.73%.

Insider Buying and Selling at Bath & Body Works, Inc.

Recent insider buying activity includes Interim CFO Tom Javitch purchasing 10,309 shares on June 12, 2026. Other executives, including Alessandro Bogliolo, Juan Rajlin, Sarah Nash, Francis Hondal, and Lucy Brady, also bought shares on June 11, 2026, with each acquiring 7,970 shares.

Analysts Set New Price Targets

On June 23, 2026, Wells Fargo maintained its buy rating on Bath & Body Works with a $26 price target. Other firms like Telsey Advisory Group and TD Cowen also maintained their ratings, with targets of $22 and $25, respectively. The consensus target price among 14 analysts is $25.57.

About Bath & Body Works

Bath & Body Works, Inc. is a specialty retailer based in Columbus, Ohio. It sells personal care and home fragrance products, including candles, soaps, lotions, and mists, under the Bath & Body Works brand. The company operates retail stores in the U.S. and Canada, as well as international locations through franchise and licensing agreements. Daniel Heaf serves as CEO, and the company employs around 9,071 people.

Bottom Line

Wells Fargo's reaffirmation of a buy rating on Bath & Body Works underscores ongoing confidence in the retailer's market position. Investors track these analyst ratings for insights into potential stock movements. It's important to note that such ratings are based on past data and may not reflect future performance.